- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis
Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-51
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
-0.060(4.12%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
$1.43 | $1.43 | $1.39 | $1.698M | 1.210M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3588 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 10711 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 26716 | 1.400 |
7 | 14901 | 1.395 |
16 | 128669 | 1.390 |
8 | 66097 | 1.385 |
24 | 178050 | 1.380 |
Price($) | Vol. | No. |
---|---|---|
1.405 | 5727 | 8 |
1.410 | 30875 | 11 |
1.415 | 53446 | 8 |
1.420 | 82251 | 7 |
1.425 | 33650 | 7 |
Last trade - 11.00am 16/10/2024 (20 minute delay) ? |
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
NEWS
Deep drilling at Mulga Bill confirms gold to 500m depth, indicating further exploration potential
MSB (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online